0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Personal Softwares Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-26Q9510
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Personal Softwares Market Research Report 2022
BUY CHAPTERS

Global Diabetes Personal Softwares Market Research Report 2025

Code: QYRE-Auto-26Q9510
Report
March 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diabetes Personal Softwares Market

The global market for Diabetes Personal Softwares was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Personal Softwares, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Personal Softwares.
The Diabetes Personal Softwares market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Personal Softwares market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Personal Softwares companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diabetes Personal Softwares Market Report

Report Metric Details
Report Name Diabetes Personal Softwares Market
Segment by Type
  • Cloud-based
  • On-premise
Segment by Application
  • Type I Diabetes
  • Type II Diabetes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd, Abbott Diabetes Care, Acon Diabetes Care International, BIONIME, Custo med, Dexcom, Dottli, GlucoMe, MyLife, Nova, Tandem Diabetes Care, Trividia Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Diabetes Personal Softwares company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diabetes Personal Softwares Market report?

Ans: The main players in the Diabetes Personal Softwares Market are Medtronic, Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd, Abbott Diabetes Care, Acon Diabetes Care International, BIONIME, Custo med, Dexcom, Dottli, GlucoMe, MyLife, Nova, Tandem Diabetes Care, Trividia Health

What are the Application segmentation covered in the Diabetes Personal Softwares Market report?

Ans: The Applications covered in the Diabetes Personal Softwares Market report are Type I Diabetes, Type II Diabetes

What are the Type segmentation covered in the Diabetes Personal Softwares Market report?

Ans: The Types covered in the Diabetes Personal Softwares Market report are Cloud-based, On-premise

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Personal Softwares Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud-based
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Diabetes Personal Softwares Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Personal Softwares Market Perspective (2020-2031)
2.2 Global Diabetes Personal Softwares Growth Trends by Region
2.2.1 Global Diabetes Personal Softwares Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetes Personal Softwares Historic Market Size by Region (2020-2025)
2.2.3 Diabetes Personal Softwares Forecasted Market Size by Region (2026-2031)
2.3 Diabetes Personal Softwares Market Dynamics
2.3.1 Diabetes Personal Softwares Industry Trends
2.3.2 Diabetes Personal Softwares Market Drivers
2.3.3 Diabetes Personal Softwares Market Challenges
2.3.4 Diabetes Personal Softwares Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Personal Softwares Players by Revenue
3.1.1 Global Top Diabetes Personal Softwares Players by Revenue (2020-2025)
3.1.2 Global Diabetes Personal Softwares Revenue Market Share by Players (2020-2025)
3.2 Global Diabetes Personal Softwares Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetes Personal Softwares Revenue
3.4 Global Diabetes Personal Softwares Market Concentration Ratio
3.4.1 Global Diabetes Personal Softwares Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Personal Softwares Revenue in 2024
3.5 Global Key Players of Diabetes Personal Softwares Head office and Area Served
3.6 Global Key Players of Diabetes Personal Softwares, Product and Application
3.7 Global Key Players of Diabetes Personal Softwares, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Personal Softwares Breakdown Data by Type
4.1 Global Diabetes Personal Softwares Historic Market Size by Type (2020-2025)
4.2 Global Diabetes Personal Softwares Forecasted Market Size by Type (2026-2031)
5 Diabetes Personal Softwares Breakdown Data by Application
5.1 Global Diabetes Personal Softwares Historic Market Size by Application (2020-2025)
5.2 Global Diabetes Personal Softwares Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetes Personal Softwares Market Size (2020-2031)
6.2 North America Diabetes Personal Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetes Personal Softwares Market Size by Country (2020-2025)
6.4 North America Diabetes Personal Softwares Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Personal Softwares Market Size (2020-2031)
7.2 Europe Diabetes Personal Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetes Personal Softwares Market Size by Country (2020-2025)
7.4 Europe Diabetes Personal Softwares Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Personal Softwares Market Size (2020-2031)
8.2 Asia-Pacific Diabetes Personal Softwares Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetes Personal Softwares Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetes Personal Softwares Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Personal Softwares Market Size (2020-2031)
9.2 Latin America Diabetes Personal Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetes Personal Softwares Market Size by Country (2020-2025)
9.4 Latin America Diabetes Personal Softwares Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Personal Softwares Market Size (2020-2031)
10.2 Middle East & Africa Diabetes Personal Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetes Personal Softwares Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetes Personal Softwares Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetes Personal Softwares Introduction
11.1.4 Medtronic Revenue in Diabetes Personal Softwares Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Glooko
11.2.1 Glooko Company Details
11.2.2 Glooko Business Overview
11.2.3 Glooko Diabetes Personal Softwares Introduction
11.2.4 Glooko Revenue in Diabetes Personal Softwares Business (2020-2025)
11.2.5 Glooko Recent Development
11.3 Accu-Chek (Roche)
11.3.1 Accu-Chek (Roche) Company Details
11.3.2 Accu-Chek (Roche) Business Overview
11.3.3 Accu-Chek (Roche) Diabetes Personal Softwares Introduction
11.3.4 Accu-Chek (Roche) Revenue in Diabetes Personal Softwares Business (2020-2025)
11.3.5 Accu-Chek (Roche) Recent Development
11.4 Tidepool
11.4.1 Tidepool Company Details
11.4.2 Tidepool Business Overview
11.4.3 Tidepool Diabetes Personal Softwares Introduction
11.4.4 Tidepool Revenue in Diabetes Personal Softwares Business (2020-2025)
11.4.5 Tidepool Recent Development
11.5 LifeScan, Inc (Platinum Equity)
11.5.1 LifeScan, Inc (Platinum Equity) Company Details
11.5.2 LifeScan, Inc (Platinum Equity) Business Overview
11.5.3 LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Introduction
11.5.4 LifeScan, Inc (Platinum Equity) Revenue in Diabetes Personal Softwares Business (2020-2025)
11.5.5 LifeScan, Inc (Platinum Equity) Recent Development
11.6 Pharmaco Diabetes
11.6.1 Pharmaco Diabetes Company Details
11.6.2 Pharmaco Diabetes Business Overview
11.6.3 Pharmaco Diabetes Diabetes Personal Softwares Introduction
11.6.4 Pharmaco Diabetes Revenue in Diabetes Personal Softwares Business (2020-2025)
11.6.5 Pharmaco Diabetes Recent Development
11.7 Ascensia Diabetes Care Holdings AG
11.7.1 Ascensia Diabetes Care Holdings AG Company Details
11.7.2 Ascensia Diabetes Care Holdings AG Business Overview
11.7.3 Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Introduction
11.7.4 Ascensia Diabetes Care Holdings AG Revenue in Diabetes Personal Softwares Business (2020-2025)
11.7.5 Ascensia Diabetes Care Holdings AG Recent Development
11.8 Diabeto Medtech India Pvt. Ltd
11.8.1 Diabeto Medtech India Pvt. Ltd Company Details
11.8.2 Diabeto Medtech India Pvt. Ltd Business Overview
11.8.3 Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Introduction
11.8.4 Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Personal Softwares Business (2020-2025)
11.8.5 Diabeto Medtech India Pvt. Ltd Recent Development
11.9 Abbott Diabetes Care
11.9.1 Abbott Diabetes Care Company Details
11.9.2 Abbott Diabetes Care Business Overview
11.9.3 Abbott Diabetes Care Diabetes Personal Softwares Introduction
11.9.4 Abbott Diabetes Care Revenue in Diabetes Personal Softwares Business (2020-2025)
11.9.5 Abbott Diabetes Care Recent Development
11.10 Acon Diabetes Care International
11.10.1 Acon Diabetes Care International Company Details
11.10.2 Acon Diabetes Care International Business Overview
11.10.3 Acon Diabetes Care International Diabetes Personal Softwares Introduction
11.10.4 Acon Diabetes Care International Revenue in Diabetes Personal Softwares Business (2020-2025)
11.10.5 Acon Diabetes Care International Recent Development
11.11 BIONIME
11.11.1 BIONIME Company Details
11.11.2 BIONIME Business Overview
11.11.3 BIONIME Diabetes Personal Softwares Introduction
11.11.4 BIONIME Revenue in Diabetes Personal Softwares Business (2020-2025)
11.11.5 BIONIME Recent Development
11.12 Custo med
11.12.1 Custo med Company Details
11.12.2 Custo med Business Overview
11.12.3 Custo med Diabetes Personal Softwares Introduction
11.12.4 Custo med Revenue in Diabetes Personal Softwares Business (2020-2025)
11.12.5 Custo med Recent Development
11.13 Dexcom
11.13.1 Dexcom Company Details
11.13.2 Dexcom Business Overview
11.13.3 Dexcom Diabetes Personal Softwares Introduction
11.13.4 Dexcom Revenue in Diabetes Personal Softwares Business (2020-2025)
11.13.5 Dexcom Recent Development
11.14 Dottli
11.14.1 Dottli Company Details
11.14.2 Dottli Business Overview
11.14.3 Dottli Diabetes Personal Softwares Introduction
11.14.4 Dottli Revenue in Diabetes Personal Softwares Business (2020-2025)
11.14.5 Dottli Recent Development
11.15 GlucoMe
11.15.1 GlucoMe Company Details
11.15.2 GlucoMe Business Overview
11.15.3 GlucoMe Diabetes Personal Softwares Introduction
11.15.4 GlucoMe Revenue in Diabetes Personal Softwares Business (2020-2025)
11.15.5 GlucoMe Recent Development
11.16 MyLife
11.16.1 MyLife Company Details
11.16.2 MyLife Business Overview
11.16.3 MyLife Diabetes Personal Softwares Introduction
11.16.4 MyLife Revenue in Diabetes Personal Softwares Business (2020-2025)
11.16.5 MyLife Recent Development
11.17 Nova
11.17.1 Nova Company Details
11.17.2 Nova Business Overview
11.17.3 Nova Diabetes Personal Softwares Introduction
11.17.4 Nova Revenue in Diabetes Personal Softwares Business (2020-2025)
11.17.5 Nova Recent Development
11.18 Tandem Diabetes Care
11.18.1 Tandem Diabetes Care Company Details
11.18.2 Tandem Diabetes Care Business Overview
11.18.3 Tandem Diabetes Care Diabetes Personal Softwares Introduction
11.18.4 Tandem Diabetes Care Revenue in Diabetes Personal Softwares Business (2020-2025)
11.18.5 Tandem Diabetes Care Recent Development
11.19 Trividia Health
11.19.1 Trividia Health Company Details
11.19.2 Trividia Health Business Overview
11.19.3 Trividia Health Diabetes Personal Softwares Introduction
11.19.4 Trividia Health Revenue in Diabetes Personal Softwares Business (2020-2025)
11.19.5 Trividia Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Diabetes Personal Softwares Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cloud-based
 Table 3. Key Players of On-premise
 Table 4. Global Diabetes Personal Softwares Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Diabetes Personal Softwares Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Diabetes Personal Softwares Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Diabetes Personal Softwares Market Share by Region (2020-2025)
 Table 8. Global Diabetes Personal Softwares Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Diabetes Personal Softwares Market Share by Region (2026-2031)
 Table 10. Diabetes Personal Softwares Market Trends
 Table 11. Diabetes Personal Softwares Market Drivers
 Table 12. Diabetes Personal Softwares Market Challenges
 Table 13. Diabetes Personal Softwares Market Restraints
 Table 14. Global Diabetes Personal Softwares Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Diabetes Personal Softwares Market Share by Players (2020-2025)
 Table 16. Global Top Diabetes Personal Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Personal Softwares as of 2024)
 Table 17. Ranking of Global Top Diabetes Personal Softwares Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Diabetes Personal Softwares Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Diabetes Personal Softwares, Headquarters and Area Served
 Table 20. Global Key Players of Diabetes Personal Softwares, Product and Application
 Table 21. Global Key Players of Diabetes Personal Softwares, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Diabetes Personal Softwares Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Diabetes Personal Softwares Revenue Market Share by Type (2020-2025)
 Table 25. Global Diabetes Personal Softwares Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Diabetes Personal Softwares Revenue Market Share by Type (2026-2031)
 Table 27. Global Diabetes Personal Softwares Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Diabetes Personal Softwares Revenue Market Share by Application (2020-2025)
 Table 29. Global Diabetes Personal Softwares Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Diabetes Personal Softwares Revenue Market Share by Application (2026-2031)
 Table 31. North America Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Diabetes Personal Softwares Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Diabetes Personal Softwares Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Diabetes Personal Softwares Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Diabetes Personal Softwares Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Diabetes Personal Softwares Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Diabetes Personal Softwares Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Diabetes Personal Softwares Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Diabetes Personal Softwares Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Diabetes Personal Softwares Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Diabetes Personal Softwares Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Diabetes Personal Softwares Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Medtronic Company Details
 Table 47. Medtronic Business Overview
 Table 48. Medtronic Diabetes Personal Softwares Product
 Table 49. Medtronic Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 50. Medtronic Recent Development
 Table 51. Glooko Company Details
 Table 52. Glooko Business Overview
 Table 53. Glooko Diabetes Personal Softwares Product
 Table 54. Glooko Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 55. Glooko Recent Development
 Table 56. Accu-Chek (Roche) Company Details
 Table 57. Accu-Chek (Roche) Business Overview
 Table 58. Accu-Chek (Roche) Diabetes Personal Softwares Product
 Table 59. Accu-Chek (Roche) Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 60. Accu-Chek (Roche) Recent Development
 Table 61. Tidepool Company Details
 Table 62. Tidepool Business Overview
 Table 63. Tidepool Diabetes Personal Softwares Product
 Table 64. Tidepool Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 65. Tidepool Recent Development
 Table 66. LifeScan, Inc (Platinum Equity) Company Details
 Table 67. LifeScan, Inc (Platinum Equity) Business Overview
 Table 68. LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Product
 Table 69. LifeScan, Inc (Platinum Equity) Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 70. LifeScan, Inc (Platinum Equity) Recent Development
 Table 71. Pharmaco Diabetes Company Details
 Table 72. Pharmaco Diabetes Business Overview
 Table 73. Pharmaco Diabetes Diabetes Personal Softwares Product
 Table 74. Pharmaco Diabetes Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 75. Pharmaco Diabetes Recent Development
 Table 76. Ascensia Diabetes Care Holdings AG Company Details
 Table 77. Ascensia Diabetes Care Holdings AG Business Overview
 Table 78. Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Product
 Table 79. Ascensia Diabetes Care Holdings AG Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 80. Ascensia Diabetes Care Holdings AG Recent Development
 Table 81. Diabeto Medtech India Pvt. Ltd Company Details
 Table 82. Diabeto Medtech India Pvt. Ltd Business Overview
 Table 83. Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Product
 Table 84. Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 85. Diabeto Medtech India Pvt. Ltd Recent Development
 Table 86. Abbott Diabetes Care Company Details
 Table 87. Abbott Diabetes Care Business Overview
 Table 88. Abbott Diabetes Care Diabetes Personal Softwares Product
 Table 89. Abbott Diabetes Care Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 90. Abbott Diabetes Care Recent Development
 Table 91. Acon Diabetes Care International Company Details
 Table 92. Acon Diabetes Care International Business Overview
 Table 93. Acon Diabetes Care International Diabetes Personal Softwares Product
 Table 94. Acon Diabetes Care International Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 95. Acon Diabetes Care International Recent Development
 Table 96. BIONIME Company Details
 Table 97. BIONIME Business Overview
 Table 98. BIONIME Diabetes Personal Softwares Product
 Table 99. BIONIME Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 100. BIONIME Recent Development
 Table 101. Custo med Company Details
 Table 102. Custo med Business Overview
 Table 103. Custo med Diabetes Personal Softwares Product
 Table 104. Custo med Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 105. Custo med Recent Development
 Table 106. Dexcom Company Details
 Table 107. Dexcom Business Overview
 Table 108. Dexcom Diabetes Personal Softwares Product
 Table 109. Dexcom Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 110. Dexcom Recent Development
 Table 111. Dottli Company Details
 Table 112. Dottli Business Overview
 Table 113. Dottli Diabetes Personal Softwares Product
 Table 114. Dottli Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 115. Dottli Recent Development
 Table 116. GlucoMe Company Details
 Table 117. GlucoMe Business Overview
 Table 118. GlucoMe Diabetes Personal Softwares Product
 Table 119. GlucoMe Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 120. GlucoMe Recent Development
 Table 121. MyLife Company Details
 Table 122. MyLife Business Overview
 Table 123. MyLife Diabetes Personal Softwares Product
 Table 124. MyLife Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 125. MyLife Recent Development
 Table 126. Nova Company Details
 Table 127. Nova Business Overview
 Table 128. Nova Diabetes Personal Softwares Product
 Table 129. Nova Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 130. Nova Recent Development
 Table 131. Tandem Diabetes Care Company Details
 Table 132. Tandem Diabetes Care Business Overview
 Table 133. Tandem Diabetes Care Diabetes Personal Softwares Product
 Table 134. Tandem Diabetes Care Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 135. Tandem Diabetes Care Recent Development
 Table 136. Trividia Health Company Details
 Table 137. Trividia Health Business Overview
 Table 138. Trividia Health Diabetes Personal Softwares Product
 Table 139. Trividia Health Revenue in Diabetes Personal Softwares Business (2020-2025) & (US$ Million)
 Table 140. Trividia Health Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Diabetes Personal Softwares Picture
 Figure 2. Global Diabetes Personal Softwares Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diabetes Personal Softwares Market Share by Type: 2024 VS 2031
 Figure 4. Cloud-based Features
 Figure 5. On-premise Features
 Figure 6. Global Diabetes Personal Softwares Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Diabetes Personal Softwares Market Share by Application: 2024 VS 2031
 Figure 8. Type I Diabetes Case Studies
 Figure 9. Type II Diabetes Case Studies
 Figure 10. Diabetes Personal Softwares Report Years Considered
 Figure 11. Global Diabetes Personal Softwares Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Diabetes Personal Softwares Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Diabetes Personal Softwares Market Share by Region: 2024 VS 2031
 Figure 14. Global Diabetes Personal Softwares Market Share by Players in 2024
 Figure 15. Global Top Diabetes Personal Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Personal Softwares as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Diabetes Personal Softwares Revenue in 2024
 Figure 17. North America Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Diabetes Personal Softwares Market Share by Country (2020-2031)
 Figure 19. United States Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Diabetes Personal Softwares Market Share by Country (2020-2031)
 Figure 23. Germany Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Diabetes Personal Softwares Market Share by Region (2020-2031)
 Figure 31. China Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Diabetes Personal Softwares Market Share by Country (2020-2031)
 Figure 39. Mexico Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Diabetes Personal Softwares Market Share by Country (2020-2031)
 Figure 43. Turkey Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Diabetes Personal Softwares Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Medtronic Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 47. Glooko Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 48. Accu-Chek (Roche) Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 49. Tidepool Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 50. LifeScan, Inc (Platinum Equity) Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 51. Pharmaco Diabetes Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 52. Ascensia Diabetes Care Holdings AG Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 53. Diabeto Medtech India Pvt. Ltd Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 54. Abbott Diabetes Care Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 55. Acon Diabetes Care International Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 56. BIONIME Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 57. Custo med Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 58. Dexcom Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 59. Dottli Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 60. GlucoMe Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 61. MyLife Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 62. Nova Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 63. Tandem Diabetes Care Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 64. Trividia Health Revenue Growth Rate in Diabetes Personal Softwares Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona